# Redwire Corp: financial statements, quarterly

RDW · NYSE · CIK 1819810 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rdw.md) · [Financials](/companies/rdw/financials.md) · [Filings](/companies/rdw/filings.md) · [Insiders](/companies/rdw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rdw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [62.6](/filings/0001819810-24-000115.md) | [63.5 d](/filings/0001819810-26-000029.md) | [87.8](/filings/0001819810-25-000137.md) | [78.1](/filings/0001819810-25-000215.md) | [68.6](/filings/0001819810-25-000248.md) | [69.6 d](/filings/0001819810-26-000029.md) | [61.4](/filings/0001819810-26-000063.md) | [61.8](/filings/0001819810-26-000124.md) | [103](/filings/0001819810-25-000248.md) | [109 d](/filings/0001819810-26-000029.md) | [97.0](/filings/0001819810-26-000063.md) | [117](/filings/0001819810-26-000124.md) |
| Cost of revenue | $m | [45.5](/filings/0001819810-24-000115.md) | [52.8 d](/filings/0001819810-26-000029.md) | [73.0](/filings/0001819810-25-000137.md) | [65.1](/filings/0001819810-25-000215.md) | [56.6](/filings/0001819810-25-000248.md) | [64.9 d](/filings/0001819810-26-000029.md) | [52.4](/filings/0001819810-26-000063.md) | [80.8](/filings/0001819810-26-000124.md) | [86.6](/filings/0001819810-25-000248.md) | [98.3 d](/filings/0001819810-26-000029.md) | [71.2](/filings/0001819810-26-000063.md) | [84.5](/filings/0001819810-26-000124.md) |
| Gross profit | $m | [17.1](/filings/0001819810-24-000115.md) | [10.7 d](/filings/0001819810-26-000029.md) | [14.8](/filings/0001819810-25-000137.md) | [13.0](/filings/0001819810-25-000215.md) | [12.0](/filings/0001819810-25-000248.md) | [4.6 d](/filings/0001819810-26-000029.md) | [9.0](/filings/0001819810-26-000063.md) | [(19.1)](/filings/0001819810-26-000124.md) | [16.8](/filings/0001819810-25-000248.md) | [10.5 d](/filings/0001819810-26-000029.md) | [25.8](/filings/0001819810-26-000063.md) | [32.5](/filings/0001819810-26-000124.md) |
| Research and development | $m | [1.5](/filings/0001819810-24-000115.md) | [1.0 d](/filings/0001819810-26-000029.md) | [1.0](/filings/0001819810-25-000137.md) | [1.7](/filings/0001819810-25-000215.md) | [1.9](/filings/0001819810-25-000248.md) | [1.4 d](/filings/0001819810-26-000029.md) | [0.8](/filings/0001819810-26-000063.md) | [1.7](/filings/0001819810-26-000124.md) | [7.7](/filings/0001819810-25-000248.md) | [9.5 d](/filings/0001819810-26-000029.md) | [12.6](/filings/0001819810-26-000063.md) | [12.5](/filings/0001819810-26-000124.md) |
| Selling, general and administrative | $m | [18.3](/filings/0001819810-24-000115.md) | [16.5 d](/filings/0001819810-26-000029.md) | [17.4](/filings/0001819810-25-000137.md) | [18.1](/filings/0001819810-25-000215.md) | [17.5](/filings/0001819810-25-000248.md) | [18.4 d](/filings/0001819810-26-000029.md) | [18.7](/filings/0001819810-26-000063.md) | [54.5](/filings/0001819810-26-000124.md) | [50.3](/filings/0001819810-25-000248.md) | [47.8 d](/filings/0001819810-26-000029.md) | [82.9](/filings/0001819810-26-000063.md) | [42.1](/filings/0001819810-26-000124.md) |
| Operating income | $m | [(2.7)](/filings/0001819810-24-000115.md) | [(6.8) d](/filings/0001819810-26-000029.md) | [(3.6)](/filings/0001819810-25-000137.md) | [(7.1)](/filings/0001819810-25-000215.md) | [(12.5)](/filings/0001819810-25-000248.md) | [(19.0) d](/filings/0001819810-26-000029.md) | [(14.3)](/filings/0001819810-26-000063.md) | [(91.9)](/filings/0001819810-26-000124.md) | [(41.9)](/filings/0001819810-25-000248.md) | [(81.6) d](/filings/0001819810-26-000029.md) | [(69.7)](/filings/0001819810-26-000063.md) | [(22.1)](/filings/0001819810-26-000124.md) |
| Income tax | $m | [(0.3)](/filings/0001819810-24-000115.md) | [(0.1) d](/filings/0001819810-26-000029.md) | [0.1](/filings/0001819810-25-000137.md) | [0.0](/filings/0001819810-25-000215.md) | [(0.5)](/filings/0001819810-25-000248.md) | [(1.7) d](/filings/0001819810-26-000029.md) | [(0.2)](/filings/0001819810-26-000063.md) | [(32.6)](/filings/0001819810-26-000124.md) | [6.9](/filings/0001819810-25-000248.md) | [0.9 d](/filings/0001819810-26-000029.md) | [0.6](/filings/0001819810-26-000063.md) | [1.9](/filings/0001819810-26-000124.md) |
| Net income | $m | [(6.3)](/filings/0001819810-24-000115.md) | [(8.3) d](/filings/0001819810-26-000029.md) | [(8.1)](/filings/0001819810-25-000137.md) | [(18.1)](/filings/0001819810-25-000215.md) | [(21.0)](/filings/0001819810-25-000248.md) | [(67.2) d](/filings/0001819810-26-000029.md) | [(2.9)](/filings/0001819810-26-000063.md) | [(97.0)](/filings/0001819810-26-000124.md) | [(41.2)](/filings/0001819810-25-000248.md) | [(85.5) d](/filings/0001819810-26-000029.md) | [(76.5)](/filings/0001819810-26-000063.md) | [(41.0)](/filings/0001819810-26-000124.md) |
| Diluted EPS | $ per share | [(0.14)](/filings/0001819810-24-000115.md) | not reported | [(0.17)](/filings/0001819810-25-000137.md) | [(0.42)](/filings/0001819810-25-000215.md) | [(0.37)](/filings/0001819810-25-000248.md) | not reported | [(0.09)](/filings/0001819810-26-000063.md) | [(1.41)](/filings/0001819810-26-000124.md) | [(0.29)](/filings/0001819810-25-000248.md) | not reported | [(0.40)](/filings/0001819810-26-000063.md) | [(0.19)](/filings/0001819810-26-000124.md) |
| Basic EPS | $ per share | [(0.14)](/filings/0001819810-24-000115.md) | not reported | [(0.17)](/filings/0001819810-25-000137.md) | [(0.42)](/filings/0001819810-25-000215.md) | [(0.37)](/filings/0001819810-25-000248.md) | not reported | [(0.09)](/filings/0001819810-26-000063.md) | [(1.41)](/filings/0001819810-26-000124.md) | [(0.29)](/filings/0001819810-25-000248.md) | not reported | [(0.40)](/filings/0001819810-26-000063.md) | [(0.19)](/filings/0001819810-26-000124.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [10.9](/filings/0001819810-24-000115.md) | [30.3](/filings/0001819810-26-000029.md) | [32.6](/filings/0001819810-24-000043.md) | [30.8](/filings/0001819810-25-000215.md) | [27.8](/filings/0001819810-25-000248.md) | [33.7](/filings/0001819810-26-000029.md) | [54.2](/filings/0001819810-26-000063.md) | [76.5](/filings/0001819810-26-000124.md) | [52.3](/filings/0001819810-25-000248.md) | [94.5](/filings/0001819810-26-000029.md) | [145](/filings/0001819810-26-000063.md) | [557](/filings/0001819810-26-000124.md) |
| Current assets | $m | [84.4](/filings/0001819810-23-000115.md) | [109](/filings/0001819810-25-000063.md) | [99.9](/filings/0001819810-24-000043.md) | [105](/filings/0001819810-24-000092.md) | [127](/filings/0001819810-24-000115.md) | [126](/filings/0001819810-26-000029.md) | [142](/filings/0001819810-25-000137.md) | [245](/filings/0001819810-25-000215.md) | [211](/filings/0001819810-25-000248.md) | [253](/filings/0001819810-26-000124.md) | [321](/filings/0001819810-26-000063.md) | [761](/filings/0001819810-26-000124.md) |
| Total assets | $m | [244](/filings/0001819810-23-000115.md) | [271](/filings/0001819810-25-000063.md) | [260](/filings/0001819810-24-000043.md) | [260](/filings/0001819810-24-000092.md) | [290](/filings/0001819810-24-000115.md) | [293](/filings/0001819810-26-000029.md) | [314](/filings/0001819810-25-000137.md) | [1,508](/filings/0001819810-25-000215.md) | [1,446](/filings/0001819810-25-000248.md) | [1,449](/filings/0001819810-26-000124.md) | [1,511](/filings/0001819810-26-000063.md) | [1,943](/filings/0001819810-26-000124.md) |
| Current liabilities | $m | [87.2](/filings/0001819810-23-000115.md) | [112](/filings/0001819810-25-000063.md) | [103](/filings/0001819810-24-000043.md) | [107](/filings/0001819810-24-000092.md) | [131](/filings/0001819810-24-000115.md) | [149](/filings/0001819810-26-000029.md) | [119](/filings/0001819810-25-000137.md) | [167](/filings/0001819810-25-000215.md) | [150](/filings/0001819810-25-000248.md) | [156](/filings/0001819810-26-000124.md) | [183](/filings/0001819810-26-000063.md) | [194](/filings/0001819810-26-000124.md) |
| Total liabilities | $m | [188](/filings/0001819810-23-000115.md) | [218](/filings/0001819810-25-000063.md) | [213](/filings/0001819810-24-000043.md) | [230](/filings/0001819810-24-000092.md) | [278](/filings/0001819810-24-000115.md) | [345](/filings/0001819810-26-000029.md) | [247](/filings/0001819810-25-000137.md) | [449](/filings/0001819810-25-000215.md) | [413](/filings/0001819810-25-000248.md) | [312](/filings/0001819810-26-000124.md) | [347](/filings/0001819810-26-000063.md) | [313](/filings/0001819810-26-000124.md) |
| Long-term debt | $m | [79.9](/filings/0001819810-23-000115.md) | [86.8](/filings/0001819810-25-000063.md) | [89.7](/filings/0001819810-24-000043.md) | [94.6](/filings/0001819810-24-000092.md) | [122](/filings/0001819810-24-000115.md) | [124](/filings/0001819810-26-000029.md) | [104](/filings/0001819810-25-000137.md) | [185](/filings/0001819810-25-000215.md) | [185](/filings/0001819810-25-000248.md) | [80.0](/filings/0001819810-26-000124.md) | [83.4](/filings/0001819810-26-000063.md) | [43.6](/filings/0001819810-26-000124.md) |
| Current portion of debt | $m | [2.0](/filings/0001819810-23-000115.md) | [1.4](/filings/0001819810-25-000063.md) | [0.8](/filings/0001819810-24-000043.md) | [0.8](/filings/0001819810-24-000092.md) | [1.8](/filings/0001819810-24-000115.md) | [1.3](/filings/0001819810-26-000029.md) | [0.8](/filings/0001819810-25-000137.md) | [5.3](/filings/0001819810-25-000215.md) | [6.3](/filings/0001819810-25-000248.md) | [5.2](/filings/0001819810-26-000124.md) | [4.8](/filings/0001819810-26-000063.md) | [4.5](/filings/0001819810-26-000124.md) |
| Shareholders' equity | $m | [(28.9)](/filings/0001819810-23-000115.md) | [(43.5)](/filings/0001819810-25-000063.md) | [(49.8)](/filings/0001819810-24-000043.md) | [(78.3)](/filings/0001819810-24-000092.md) | [(96.4)](/filings/0001819810-24-000115.md) | [(189)](/filings/0001819810-26-000029.md) | [(68.1)](/filings/0001819810-25-000137.md) | [908](/filings/0001819810-25-000215.md) | [928](/filings/0001819810-25-000248.md) | [1,060](/filings/0001819810-26-000124.md) | [1,088](/filings/0001819810-26-000063.md) | [1,630](/filings/0001819810-26-000124.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(3.3) d](/filings/0001819810-24-000115.md) | [15.7 d](/filings/0001819810-26-000029.md) | [2.8](/filings/0001819810-25-000137.md) | [(9.5) d](/filings/0001819810-25-000215.md) | [(17.7) d](/filings/0001819810-25-000248.md) | [7.1 d](/filings/0001819810-26-000029.md) | [(45.1)](/filings/0001819810-26-000063.md) | [(87.7) d](/filings/0001819810-26-000124.md) | [(20.3) d](/filings/0001819810-25-000248.md) | [(24.3) d](/filings/0001819810-26-000029.md) | [(6.7)](/filings/0001819810-26-000063.md) | [(24.9) d](/filings/0001819810-26-000124.md) |
| Capital expenditure | $m | [1.3 d](/filings/0001819810-24-000115.md) | [2.1 d](/filings/0001819810-26-000029.md) | [1.6](/filings/0001819810-25-000137.md) | [0.9 d](/filings/0001819810-25-000215.md) | [1.6 d](/filings/0001819810-25-000248.md) | [2.3 d](/filings/0001819810-26-000029.md) | [1.8](/filings/0001819810-26-000063.md) | [3.0 d](/filings/0001819810-26-000124.md) | [6.5 d](/filings/0001819810-25-000248.md) | [2.2 d](/filings/0001819810-26-000029.md) | [4.8](/filings/0001819810-26-000063.md) | [8.5 d](/filings/0001819810-26-000124.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [63.5](/filings/0001819810-23-000115.md) | [64.3](/filings/0001819810-24-000043.md) | [64.3](/filings/0001819810-24-000092.md) | [64.8](/filings/0001819810-24-000115.md) | [65.6](/filings/0001819810-25-000137.md) | [65.7](/filings/0001819810-25-000215.md) | [66.5](/filings/0001819810-25-000248.md) | [71.2](/filings/0001819810-26-000063.md) | [89.6](/filings/0001819810-26-000124.md) | [146](/filings/0001819810-25-000248.md) | [194](/filings/0001819810-26-000063.md) | [220](/filings/0001819810-26-000124.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 249,992,609 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001819810-26-000124.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.